Innovation Days
About
Research
Products
Investors
Careers
Agenda
fr
Press Releases
Our latest news and press releases
All
2022
2021
2020
2019
2018
2017
19
Oct
2021
14:19 E.S.T.
Cellectis Presents Initial Preclinical Data on Two Novel Gene Therapies for Patients with RAG1 Severe Combined Immunodeficiency (SCID) and Hyper IgE syndrome at ESGCT 2021
Read more
12
Oct
2021
14:53 E.S.T.
Cellectis to Present Preclinical Data on UCARTMESO Supporting Anti-Tumor Activity at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Read more
26
Aug
2021
14:38 E.S.T.
Cellectis Announces Participation in Five Investor Conferences
Read more
05
Aug
2021
14:43 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021
Read more
29
Jul
2021
16:06 E.S.T.
Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT
Read more
14
Jun
2021
14:11 E.S.T.
Cellectis’ Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturing Capabilities
Read more
02
Jun
2021
02:35 E.S.T.
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 1, 2021
Read more
11
May
2021
13:05 E.S.T.
Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
Read more
06
May
2021
14:28 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
Read more
26
Apr
2021
15:06 E.S.T.
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021
Read more
Prev
1
2
3
4
5
Next